Demographic, medical, and psychological characteristics of study sample.
| Characteristic | n = 294 |
|---|---|
| Demographic | |
| Mean age (SD), yrs | 45.1 (14.40) |
| Mean education level, yrs (1–5) (SD) | 3.7 (1.26) |
| Male, n (%) | 197 (68.2) |
| White, n (%) | 241 (82.0) |
| No. employed (%) | 192 (65.5) |
| No. students (%) | 26 (8.9) |
| No. smokers (%) | 32 (11.0) |
| No. married (%) | 153 (55.8) |
| Medical | |
| Mean no. medical comorbidities (0–4) (SD) | 2.0 (1.34) |
| Current NSAID use, (%) | 136 (46.6) |
| Current biologic use, (%) | 132 (45.2) |
| Mean C-reactive protein, mg/dl, (SD) | 0.9 (1.79) |
| Mean disease duration, yrs (SD) | 21.2 (13.85) |
| Mean BASRI score (1.5–16) (SD) | 6.5 (4.27) |
| Psychological | |
| Mean resilience coping (BRCS) score (0–20) (SD) | 16.1 (3.33) |
| Mean arthritis internality score (6–36) (SD) | 25.7 (5.94) |
| Mean arthritis helplessness score (5–25) (SD) | 12.4 (4.41) |
| Mean depression (PHQ-9) score (0–27) (SD) | 5.1 (5.01) |
| Mean active coping score (7–35) (SD) | 22.7 (5.22) |
| Mean passive coping score (11–55) (SD) | 25.6 (7.45) |
NSAID: nonsteroidal antiinflammatory drug; BASRI: Bath Ankylosing Spondylitis Radiographic Index; BRCS: Brief Resilient Coping Scale; PHQ: Patient Health Questionnaire.